×
About 255 results

ALLMedicine™ Pleural Effusions Center

Research & Reviews  100 results

Outcomes for Malignant Pleural Effusions Because of Melanoma Treated With Indwelling Pl...
https://doi.org/10.1097/LBR.0000000000000877
Journal of Bronchology & Interventional Pulmonology; Masoudian P, Kwok C et. al.

Jul 23rd, 2022 - Indwelling pleural catheters (IPCs) reduce dyspnea and improve quality of life in patients with malignant pleural effusions (MPEs). Data on outcomes of MPEs secondary to metastatic melanoma managed with IPCs are scarce. We aimed to evaluate outcom...

Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effu...
https://doi.org/10.1097/LBR.0000000000000871
Journal of Bronchology & Interventional Pulmonology; Chan C, Sekowski V et. al.

Jun 15th, 2022 - Indwelling pleural catheters (IPCs) are frequently used for the management of malignant pleural effusions (MPEs), but drainage can be impaired by pleural loculations. We aimed to evaluate the safety and effectiveness of intrapleural tissue plasmin...

Deconvolution of malignant pleural effusions immune landscape unravels a novel macropha...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119185
Journal for Immunotherapy of Cancer; Bruschini S, Pallocca M et. al.

May 19th, 2022 - Immune checkpoint inhibitors are still unable to provide clinical benefit to the large majority of non-small cell lung cancer (NSCLC) patients. A deeper characterization of the tumor immune microenvironment (TIME) is expected to shed light on the ...

Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastat...
https://doi.org/10.1016/j.imlet.2022.04.003
Immunology Letters; Zhang Y, Li W et. al.

Apr 17th, 2022 - Highly coordinated signaling following TCR stimulation triggers activation and subsequent differentiation of T cells. CD38 is a major mammalian nicotinamide adenine dinucleotide (NAD)+ glycohydrolase expressed on T cells, and appears to be an impo...

Update on the diagnosis and management of malignant pleural effusions.
https://doi.org/10.1016/j.rmed.2022.106802
Respiratory Medicine; Bashour SI, Mankidy BJ et. al.

Mar 15th, 2022 - Roughly 150,000 malignant pleural effusions (MPE) are diagnosed in the United States each year. The majority of cases are caused by lung and breast cancer, and since MPE represents advanced disease, the prognosis is generally poor. In this article...

see more →

Guidelines  1 results

ERS/EACTS statement on the management of malignant pleural effusions.
https://doi.org/10.1183/13993003.00349-2018
The European Respiratory Journal; Bibby AC, Dorn P et. al.

Jul 29th, 2018 - Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomised clinical trials have been published that have changed the landscape of MPE m...

see more →

News  1 results

Cardiovascular Medicine and Surgery NetWork
https://www.mdedge.com/chestphysician/article/214641/society-news/cardiovascular-medicine-and-surgery-network/page/0/1?channel=28399

Jan 17th, 2020 - Clinical pulmonary medicine Definitive pleural interventions in malignant pleural effusions Malignant pleural effusions (MPEs) contribute significantly to symptom burden, and an emphasis on patient-centered outcomes prioritizes palliation of sympt.

see more →